ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360 | -16.9% | 17,288 | -4.3% | 0.03% | -20.6% |
| Q2 2023 | $433 | +22.0% | 18,068 | -4.2% | 0.03% | +30.8% |
| Q1 2023 | $355 | -23.5% | 18,867 | -35.3% | 0.03% | -33.3% |
| Q4 2022 | $464 | -99.9% | 29,170 | +6.4% | 0.04% | -7.1% |
| Q3 2022 | $448,000 | +24.1% | 27,407 | +7.0% | 0.04% | +27.3% |
| Q2 2022 | $361,000 | +28.9% | 25,621 | +121.4% | 0.03% | +266.7% |
| Q1 2022 | $280,000 | +58.2% | 11,573 | +8.4% | 0.01% | +28.6% |
| Q3 2021 | $177,000 | – | 10,673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |